CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company, announced a new collaboration with the American College of Cardiology to join its Innovation Program and ...
The FDA-cleared Zio patch is placed over a patient’s heart for up to 14 days, where it monitors the heartbeat and generates reports about the individual’s heart rhythm, automatically highlighting any ...
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...
This article is authored by Dr. Ashok Punjabi is a consultant cardiologist with 40 years of non-invase and invasive ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that three abstracts featuring Viz HCM, the company’s AI-powered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results